Literature DB >> 17223646

Carbohydrate-recognition domains of galectin-9 are involved in intermolecular interaction with galectin-9 itself and other members of the galectin family.

Nobumitsu Miyanishi1, Nozomu Nishi, Hiroko Abe, Yumiko Kashio, Rika Shinonaga, Shin-ichi Nakakita, Wataru Sumiyoshi, Akira Yamauchi, Takanori Nakamura, Mitsuomi Hirashima, Jun Hirabayashi.   

Abstract

Galectin-9 (Gal-9) is a tandem-repeat-type member of the galectin family associated with diverse biological processes, such as apoptosis, cell aggregation, and eosinophil chemoattraction. Although the detailed sugar-binding specificity of Gal-9 has been elucidated, molecular mechanisms that underlie these functions remain to be investigated. During the course of our binding study by affinity chromatography and surface plasmon resonance (SPR) analysis, we found that human Gal-9 interacts with immobilized Gal-9 in the protein-protein interaction mode. Interestingly, this intermolecular interaction strongly depended on the activity of the carbohydrate recognition domain (CRD), because the addition of potent saccharide inhibitors abolished the binding. The presence of multimers was also confirmed by Ferguson plot analysis of result of polyacrylamide gel electrophoresis and matrix-assisted laser-desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (MS). Moreover, this intermolecular interaction was observed between Gal-9 and other galectin members, such as Gal-3 and Gal-8, but not Gal-1. Because such properties have not been reported yet, they may explain an unidentified mechanism underlying the diverse functions of Gal-9.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17223646     DOI: 10.1093/glycob/cwm001

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  14 in total

1.  Galectin multimerization and lattice formation are regulated by linker region structure.

Authors:  Lesley A Earl; Shuguang Bi; Linda G Baum
Journal:  Glycobiology       Date:  2010-09-23       Impact factor: 4.313

2.  Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways.

Authors:  Shuguang Bi; Lesley A Earl; Linsey Jacobs; Linda G Baum
Journal:  J Biol Chem       Date:  2008-02-07       Impact factor: 5.157

3.  Isolation of novel prototype galectins from the marine ball sponge Cinachyrella sp. guided by their modulatory activity on mammalian glutamate-gated ion channels.

Authors:  Takuya Ueda; Yuka Nakamura; Caleb M Smith; Bryan A Copits; Akira Inoue; Takao Ojima; Satoko Matsunaga; Geoffrey T Swanson; Ryuichi Sakai
Journal:  Glycobiology       Date:  2012-12-04       Impact factor: 4.313

Review 4.  Evolving mechanistic insights into galectin functions.

Authors:  Connie M Arthur; Marcelo Dias Baruffi; Richard D Cummings; Sean R Stowell
Journal:  Methods Mol Biol       Date:  2015

Review 5.  Galectin-9: From cell biology to complex disease dynamics.

Authors:  Sebastian John; Rashmi Mishra
Journal:  J Biosci       Date:  2016-09       Impact factor: 1.826

6.  X-ray structures of human galectin-9 C-terminal domain in complexes with a biantennary oligosaccharide and sialyllactose.

Authors:  Hiromi Yoshida; Misa Teraoka; Nozomu Nishi; Shin-ichi Nakakita; Takanori Nakamura; Mitsuomi Hirashima; Shigehiro Kamitori
Journal:  J Biol Chem       Date:  2010-09-22       Impact factor: 5.157

7.  Galectin-9 trafficking regulates apical-basal polarity in Madin-Darby canine kidney epithelial cells.

Authors:  Rashmi Mishra; Michal Grzybek; Toshiro Niki; Mitsuomi Hirashima; Kai Simons
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-22       Impact factor: 11.205

8.  Galectins in the Pathogenesis of Rheumatoid Arthritis.

Authors:  Song Li; Yangsheng Yu; Christopher D Koehn; Zhixin Zhang; Kaihong Su
Journal:  J Clin Cell Immunol       Date:  2013-09-30

Review 9.  Galectins as Molecular Targets for Therapeutic Intervention.

Authors:  Ruud P M Dings; Michelle C Miller; Robert J Griffin; Kevin H Mayo
Journal:  Int J Mol Sci       Date:  2018-03-19       Impact factor: 5.923

Review 10.  Utilization of Galectins by Pathogens for Infection.

Authors:  Diyoly Ayona; Pierre-Edouard Fournier; Bernard Henrissat; Benoit Desnues
Journal:  Front Immunol       Date:  2020-08-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.